Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-04-18
2006-04-18
O'Hara, Eileen B. (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007200, C435S325000, C435S348000, C435S357000, C435S361000, C435S356000, C435S365000, C435S369000, C435S354000, C435S320100, C530S356000, C536S023500
Reexamination Certificate
active
07029857
ABSTRACT:
This invention provides isolated nucleic acids encoding mammalian SNORF62 and SNORF72 receptors, purified mammalian SNORF62 and SNORF72 receptors, vectors comprising nucleic acid encoding mammalian SNORF62 and SNORF72 receptors, cells comprising such vectors, antibodies directed to mammalian SNORF62 and SNORF72 receptors, nucleic acid probes useful for detecting nucleic acid encoding mammalian SNORF62 and SNORF72 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding mammalian SNORF62 and SNORF72 receptors, transgenic, nonhuman animals which express DNA encoding normal or mutant mammalian SNORF62 and SNORF72 receptors, methods of isolating mammalian SNORF62 and SNORF72 receptors, methods of treating an abnormality that is linked to the activity of the mammalian SNORF62 and SNORF72 receptors, as well as methods of determining binding of compounds to mammalian SNORF62 and SNORF72 receptors, methods of identifying agonists and antagonists of SNORF62 and SNORF72 receptors, and agonists and antagonists so identified. This invention also provides methods of treating an abnormality that is linked to the activity of a mammalian NMU receptor, as well as methods of determining binding of compounds to mammalian NMU receptors, methods of identifying agonists and antagonists of NMU receptors, and agonists and antagonists so identified.
REFERENCES:
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 6383761 (2002-05-01), Conklin et al.
patent: 6461836 (2002-10-01), Elshourbagy et al.
patent: 9955732 (1999-11-01), None
patent: 0002919 (2000-01-01), None
patent: 0022131 (2000-04-01), None
patent: WO 00/22131 (2000-04-01), None
patent: WO 00/22131 (2000-04-01), None
patent: 0031258 (2000-06-01), None
patent: WO0031258 (2000-06-01), None
patent: 0125269 (2001-04-01), None
Vukicevic et al., 1996, PNAS USA 93:9021-9026.
Derwent Database Accession No. Y44641 (published Apr. 18, 2000).
Derwent Database Accession No. Z49707 (published Apr. 18, 2000).
Derwent Database Accession No. Z49706 (published Apr. 18, 2000).
Derwent Database Accession No. Y44642 (published Apr. 18, 2000).
Derwent Database Accession No. Z33297 (published Feb. 21, 2000).
Derwent Database Accession No. Y52992 (published Feb. 21, 2000).
HTG Database Accession No. AC017104 (published Dec. 10, 1999).
HTG Database Accession No. AC008571 (published Aug. 3, 1999).
GSS Database Accession No. AQ019411 (published Jun. 9, 1998).
GSS Database Accession No. AQ015065 (published Jun. 9, 1998).
SwissProtPlus Database Accession No. O43664 (published Jun. 1, 1998).
SwissProtPlus Database Accession No. O55040 (published Jun. 1, 1998).
GenEMBL Database Accession No. AF044600 (published Feb. 12, 1998).
GenEMBL Database Accession No. AF044601 (published Feb. 12, 1998).
GenEMBL Database Accession No. AF044602 (published Feb. 12, 1998).
Expressed Sequence Tags Database Accession No. AA562357 (published Aug. 19, 1997).
Expressed Sequence Tags Database Accession No. N45474 (published Feb. 16, 1996).
Expressed Sequence Tags Database Accession No. H11359 (published Jun. 28, 1995).
Expressed Sequence Tags Database Accession No. R13353 (published Apr. 13, 1995).
Expressed Sequence Tags Database Accession No. R13890 (published Apr. 13, 1995).
Tan, C.P., et al.Genomics(1998) 52(2), 223-229.
Fujii, R., et al.,J. Biol. Chem., Apr. 26, 2000.
Szekeres, P.G., et al.,J. Biol. Chem., May 12, 2000.
Fujii, R., et al., “Identification of Neuromedin U as the Cognate Ligand of the Orphan G Protein-Coupled Receptor FM-3”, Jul. 14, 2000, J. Biol. Chem., 275(28): 21068-21074.
Hosoya, M., et al., “Identification and Functional Characterization of a Novel Subtype of Neuromedin U Receptor”, Jul. 7, 2000, (e pub ahead of print).
Howard, A., et al., Identification of receptors for neuromedin U and its role in feeding, Jul. 6, 2000, Nature, 406:70-74.
Szekeres, P., et al., “Neuromedin U Is a Potent Agonist at the Orphan G Protein-coupled Receptor FM3”, Jul. 7, 2000, J. Biol. Chem., 275(27): 20247-20250.
Skolnick, J. and J.S. Fetrow, “From genes to protein structure and function: novel applications of computational approaches in the genomic era”, Trends in Biotechnology 18(1): 34-39 (2000).
GenEMBL Database Accession No. AC008571 (published Aug. 4, 1999) (Exhibit 1).
GenEMBL Database Accession No. HS474279 (published Feb. 17, 1996) (Exhibit 2).
GenEMBL Database Accession No. 055040 (published Jun. 1, 1998) (Exhibit 3).
GenEMBL Database Accession No. AAY71296 (published Nov. 2, 2000) (Exhibit 4).
GenEMBL Database Accession No. AAB02830 (published Aug. 22, 2000) (Exhibit 5).
Bonini James A.
Lerman Gabriel S.
Ogozalek Kristine L.
Quan Yong
H. Lundbeck A/S
Kalinchak Stephen B.
O'Hara Eileen B.
LandOfFree
Processes for obtaining compounds employing SNORF72 receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Processes for obtaining compounds employing SNORF72 receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Processes for obtaining compounds employing SNORF72 receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3564398